Sonova, CH0012549785

Update, Sonova highlights analyst views, shares in SMI healthcare

Published on 06/23/2026 at 20:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Updated at 07:12. Sonova keeps the spotlight on analyst views and strategy, with UBS reiterating a Buy rating and consensus data pointing to a low-300 Swiss franc target range.

Sonova, CH0012549785, Illustration mit AI erstellt.
Sonova, CH0012549785, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 18:36.

Update 0. Previous article at 07:12.

Sonova (CH0012549785) keeps a firm place in the SMI healthcare group on the SIX Swiss Exchange. UBS has reiterated a Buy rating, and consensus data points to a low-300 Swiss franc target range according to the live Sonova market note.

UBS stays positive

Sonova Holding AG remains tied to the Swiss large-cap healthcare set, with Roche and Novartis as the closest index peers in the SMI. The latest market note also places the hearing-care group in a clear analyst framework, with UBS cited as the named house.

Consensus aggregators in the same Sonova note point to a price target in the low-300 franc area. The article also lists the shares at 250 Swiss francs on 2026-06-22 at 17:30, a concrete reference point for the current valuation discussion.

SMI context today

Sonova’s SMI membership matters because the index keeps the stock in the Swiss blue-chip conversation. In that setting, analyst updates carry weight alongside the broader healthcare peer group on the SIX Swiss Exchange.

Reuters-style market commentary is not required to see the setup here: the combination of a named Buy rating, a price-target range and an SMI listing already frames the current debate around the shares.

Go deeper

All news and analysis on the Sonova shares

The hearing-care group stays on the SIX Swiss Exchange, with analyst views and price references shaping the current picture.

Hearing aids drive revenue

Sonova’s core business centers on hearing aids and cochlear implant systems, with the Phonak brand as one of its best-known product lines. The group also serves audiology and hearing-care channels through its broader portfolio.

Six Swiss Exchange price

The Sonova shares (CH0012549785) trade on 2026-06-22, 17:30 on the SIX Swiss Exchange at 250 Swiss francs.

Key data on the Sonova shares

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • WKN: 12549785
  • Ticker: SOON
  • Trading venue: SIX Swiss Exchange
  • Price (as of 2026-06-22, 17:30): 250 CHF
  • Market cap: 15,000,000,000 CHF (as of 2026-06-22)
  • Sector / industry: Healthcare equipment and supplies, hearing-care devices
  • Index membership: SMI
  • Next earnings date: 2026-08-20

More on the Sonova shares in social media

This article is for information only and does not constitute investment advice.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0012549785 | SONOVA | boerse | 69613086 | bgmi